333 related articles for article (PubMed ID: 15626951)
1. Population immunity to polioviruses among preschool children from four urban underserved low income communities, United States, 1997-2001.
Prevots DR; Pascual FB; Angellili ML; Brayden R; Irigoyen M; Larussa P; Sawyer M; Baughman AL; Pallansch MA
Pediatr Infect Dis J; 2004 Dec; 23(12):1130-6. PubMed ID: 15626951
[TBL] [Abstract][Full Text] [Related]
2. Anomalous observations on IPV and OPV vaccination.
John TJ
Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
[TBL] [Abstract][Full Text] [Related]
3. Impact of the sequential IPV/OPV schedule on vaccination coverage levels--United States, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 Dec; 47(47):1017-9. PubMed ID: 9853937
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of poliovirus antibodies among children in a Dominican community--Puerto Rico, 2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Jun; 54(23):580-1. PubMed ID: 15959453
[TBL] [Abstract][Full Text] [Related]
6. Ensuring preparedness for potential poliomyelitis outbreaks: Recommendations for the US poliovirus vaccine stockpile from the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP).
Alexander L; Birkhead G; Guerra F; Helms C; Hinman A; Katz S; LeBaron CW; Modlin J; Murphy TV; ;
Arch Pediatr Adolesc Med; 2004 Dec; 158(12):1106-12. PubMed ID: 15583093
[TBL] [Abstract][Full Text] [Related]
7. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.
Viviani S; Mendy M; Jack AD; Hall AJ; Montesano R; Whittle HC
Trop Med Int Health; 2004 Oct; 9(10):1044-9. PubMed ID: 15482396
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria.
Giwa FJ; Olayinka AT; Ogunshola FT
Vaccine; 2012 Nov; 30(48):6759-65. PubMed ID: 23000220
[TBL] [Abstract][Full Text] [Related]
9. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States.
Chen RT; Hausinger S; Dajani AS; Hanfling M; Baughman AL; Pallansch MA; Patriarca PA
JAMA; 1996 Jun; 275(21):1639-45. PubMed ID: 8637136
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies.
Pírez MC; Olivera I; Diabarboure H; Montano A; Barañano R; Badía F; Bonnet MC
Vaccine; 2009 May; 27(20):2689-94. PubMed ID: 19428880
[TBL] [Abstract][Full Text] [Related]
12. [German Health survey 1997/98: immune status against poliomyelitis].
Diedrich S; Claus H; Thierfelder W; Bellach BM; Schreier E
Dtsch Med Wochenschr; 2000 May; 125(19):584-8. PubMed ID: 11320716
[TBL] [Abstract][Full Text] [Related]
13. Antibody levels against polioviruses in children following Pulse Polio Immunization Program.
Hasan AS; Malik A; Shukla I; Malik MA
Indian Pediatr; 2004 Oct; 41(10):1040-4. PubMed ID: 15523131
[TBL] [Abstract][Full Text] [Related]
14. The role of routine polio immunization in the post-certification era.
Sutter RW; Cáceres VM; Mas Lago P
Bull World Health Organ; 2004 Jan; 82(1):31-9. PubMed ID: 15106298
[TBL] [Abstract][Full Text] [Related]
15. A survey for neutralizing antibodies to the three types of poliovirus among children in Maiduguri, Nigeria.
Baba MM; Haruna BA; Ogunmola O; Ambe JP; Shidali NN; Oderinde B; Marcello A; Talle M
J Med Virol; 2012 Apr; 84(4):691-6. PubMed ID: 22337311
[TBL] [Abstract][Full Text] [Related]
16. [Post-vaccination anti-poliomyelitis seroprevalence in an urban setting in Abidjan].
Akoua-Koffi G; Thonnon J; Kouassi-Renaud M; Dosso M; Ehouman A
Bull Soc Pathol Exot; 1995; 88(3):117-20. PubMed ID: 8555765
[TBL] [Abstract][Full Text] [Related]
17. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP).
Prevots DR; Burr RK; Sutter RW; Murphy TV;
MMWR Recomm Rep; 2000 May; 49(RR-5):1-22; quiz CE1-7. PubMed ID: 15580728
[TBL] [Abstract][Full Text] [Related]
18. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing antibodies against poliovirus serotypes among children in southwest Nigeria.
Adewumi MO; Donbraye E; Odaibo GN; Bakarey AS; Opaleye OO; Olaleye DO
J Trop Pediatr; 2006 Apr; 52(2):92-5. PubMed ID: 16014758
[TBL] [Abstract][Full Text] [Related]
20. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.
Mas Lago P; Ramon Bravo J; Andrus JK; Comellas MM; Galindo MA; de Quadros CA; Bell E
Bull World Health Organ; 1994; 72(2):221-5. PubMed ID: 8205641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
